期刊文献+

以咽喉疼痛为首发症状的白塞病临床诊治分析

Analysis of clinical diagnosis and treatment of Behcet's disease with sore throat as the first symptom
原文传递
导出
摘要 目的:总结以咽喉疼痛为首发症状的白塞病的临床及诊疗特点,以提高临床医师对该病的认识。方法:回顾性分析2015年1月—2022年1月首诊于北京协和医院耳鼻咽喉科的28例白塞病患者的临床资料。所有患者初诊时均行电子鼻咽喉镜检查,并予以局部对症治疗。21例患者行C反应蛋白及血沉检查,另有部分患者行免疫指标检查。明确白塞病诊断后,治疗以免疫抑制剂为主,可根据病变程度及其他器官累及情况辅以口服激素治疗。结果:所有患者均以咽喉疼痛为首发症状,可伴有吞咽困难或呼吸困难,内镜检查发现口咽部溃疡25例(89.3%),喉部溃疡15例(53.6%),下咽部溃疡14例(50.0%),伴有鼻咽或咽喉粘连8例(28.6%)。所有患者均同时存在口腔溃疡,伴发生殖器溃疡者21例(75.0%),皮肤损害18例(64.3%),眼部病变11例(39.3%)。病程中伴关节受累4例(14.3%),神经系统病变3例(10.7%),消化系统病变1例(3.6%)。结论:以咽喉疼痛为首发症状的白塞病临床表现多样,溃疡可累及咽喉部多个部位,少数患者可累及全身多系统。临床上需予以重视,应尽早诊断、及时治疗,防止或延缓病变累及重要器官或系统。 Objective:To summarize the clinical and diagnostic characteristics of Behcet's disease with sore throat as the first symptom,so as to improve clinicians' understanding of the disease.Methods:The clinical data of 28 patients with Behcet's disease who were first treated in Department of Otorhinolaryngology,Peking Union Medical College Hospital from January 2015 to January 2022 were analyzed retrospectively.All patients were examined by electronic laryngoscopy at the first visit and treated with local symptomatic therapy.Twenty-one patients were examined for C-reactive protein and blood sedimentation,and some patients were examined for immunological parameters.After the diagnosis of leukoaraiosis was confirmed,treatment was based on immunosuppression and could be supplemented with oral hormone therapy depending on the extent of the lesion and other organ involvement.Results:Sore throat was the first symptom of all patients,which could be accompanied by dysphagia or dyspnea.Endoscopy revealed oropharyngeal ulcer in 25 cases(89.3%),laryngeal ulcer in 15 cases(53.6%),hypopharyngeal ulcer in 14 cases(50.0%),and adhesion of nasopharynx or throat in 8 cases(28.6%).All patients had oral ulcer at the same time,including 21 cases(75.0%) with genital ulcer,18 cases(64.3%) with skin damage,and 11 cases(39.3%) with eye disease.In the course of disease,there were 4 cases(14.3%) with joints involvement,3 cases(10.7%) with nervous system disease,and 1 case(3.6%) with digestive system disease.The treatment is mainly immunosuppressive,and oral hormone therapy can be supplemented according to the extent of the disease and the involvement of other organs.Conclusion:The clinical manifestations of Beh9et's disease,with sore throat as the first symptom,are diverse.The ulcer may involve multiple parts of the throat,and a few patients may involve multiple systems of the whole body.Clinical attention should be paid to the early diagnosis and timely treatment to prevent or delay the involvement of the lesion in important organs or systems.
作者 刁文雯 朱莹莹 陈兴明 祝小莉 DIAO Wenwen;ZHU Yingying;CHEN Xingming;ZHU Xiaoli(Department of Otorhinolaryngology,Peking Union Medical College Hospital,Chinese Academy of Medical Sciences&Peking Union Medical College,Beijing,100730,China)
出处 《临床耳鼻咽喉头颈外科杂志》 CAS CSCD 北大核心 2023年第2期127-132,共6页 Journal of Clinical Otorhinolaryngology Head And Neck Surgery
基金 中央高水平医院临床科研业务费资助(No:2022-PUMCH-B-094)。
关键词 白塞病 咽喉疼痛 临床诊治 Behcet's disease sore throat clinical diagnosis and treatment
  • 相关文献

参考文献3

二级参考文献22

  • 1张卓莉,彭劲民,侯小萌,董怡.1996例白塞病患者的临床荟萃分析[J].北京医学,2007,29(1):10-12. 被引量:67
  • 2董怡.贝赫切特病[A].蒋明 DavidYu 林孝义.中华风湿病学[C].北京:华夏出版社,2004.1194-1203.
  • 3Aydintug AO,Tokgo ZG,D'Cruz DP,et al.Antibodies to endothelial cells in patients with Behcet's disease.Immunol Immunopathol,1993,67:157-162.
  • 4Lelkes PI.Conference report.Endothelial cell heterogeneity and organ specificity.Endothelium,1993,1:69-70.
  • 5Salohn KV,Tonqueze LE,Nassovov EL,et al.Anti-endothelial cell antibodies in patients with various forms of vasculitis.Clin Exp Rheumatol,1996,14:163-169.
  • 6Del Papa N,Gambini D,Meroni PL.Anti-endothelial cell antibodies and autoimmune disease.Clin Rev Allergy,1994,12:275-286.
  • 7Cervera R,Navarro M,Lopez-Soto A,et al.Antibodies to endothelial cells in Behcet's disease:cell-binding heterogeneity and association with clinical activity.Ann Rheum Dis,1994,53:265-267.
  • 8Lee KH,Chung HS,Kim HS,et al.Human alpha-enolase from endothelial cell as a target antigen of anti-endothelial cell antibody in Behect's disease.Arthritis Rheum,1996,39:758-766.
  • 9Kosar A,Ozturk M,Haznedaroglu IC,et al.Hemostatic parameters in Behcet's disease:a reappraisal.Rheumatol Int,2002,22:9-15.
  • 10Praprotnik S,Blank M,Meroni PL,et al.Classification of anti-endothelial cell antibodies into antibodies against microvascular and macrovascular endothelial cells.Arthritis Rheum,2001,44:1484-1494.

共引文献144

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部